Quick Answer
HAEMONETICS CORP reported Cash And Cash Equivalents At Carrying Value of $306.76 million for the year ending 2025.
- HAEMONETICS CORP showed an increase of +71.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from HAEMONETICS CORP's annual report (Form 10-K), filed with the SEC on May 21, 2025.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2008 to 2025), HAEMONETICS CORP's Cash And Cash Equivalents At Carrying Value has grown by 129.7%.
- Historical annual values: Fiscal year 2025: $306.76 million | Fiscal year 2024: $178.80 million | Fiscal year 2023: $284.47 million | Fiscal year 2022: $259.50 million | Fiscal year 2021: $192.31 million | Fiscal year 2020: $137.31 million | Fiscal year 2019: $169.35 million | Fiscal year 2018: $180.17 million | Fiscal year 2017: $139.56 million | Fiscal year 2016: $115.12 million | Fiscal year 2015: $160.66 million | Fiscal year 2014: $192.47 million | Fiscal year 2013: $179.12 million | Fiscal year 2012: $228.86 million | Fiscal year 2011: $196.71 million | Fiscal year 2010: $141.56 million | Fiscal year 2009: $156.72 million | Fiscal year 2008: $133.55 million.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: